Next Article in Journal
Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination
Next Article in Special Issue
Acute Effects of Ocrelizumab Infusion in Multiple Sclerosis Patients
Previous Article in Journal
circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets, Insulin-like Growth Factor Binding Protein 2 (IGFBP2) and NRAS Proto-Oncogene, GTPase (NRAS) in Glioblastoma
Previous Article in Special Issue
Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2022, 23(22), 13677; https://doi.org/10.3390/ijms232213677
Action Date Notes Link
article html file updated 28 December 2025 22:02 CET Update https://www.mdpi.com/1422-0067/23/22/13677/html
article html file updated 3 September 2025 05:56 CEST Update -
article html file updated 2 March 2023 21:43 CET Update -
article html file updated 28 February 2023 21:58 CET Update -
article html file updated 21 November 2022 07:49 CET Original file -
article supplementary file uploaded. 21 November 2022 07:48 CET - https://www.mdpi.com/1422-0067/23/22/13677#supplementary
article pdf uploaded. 21 November 2022 07:48 CET Updated version of record https://www.mdpi.com/1422-0067/23/22/13677/pdf
article xml uploaded. 21 November 2022 07:48 CET Update https://www.mdpi.com/1422-0067/23/22/13677/xml
article xml file uploaded 21 November 2022 07:48 CET Original file -
article pdf uploaded. 8 November 2022 10:25 CET Version of Record https://www.mdpi.com/1422-0067/23/22/13677/pdf-vor
Back to TopTop